148 related articles for article (PubMed ID: 7703042)
1. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome.
Möttönen M; Lanning M; Saarinen UM
Pediatr Hematol Oncol; 1995; 12(1):55-9. PubMed ID: 7703042
[TBL] [Abstract][Full Text] [Related]
2. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.
Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K
Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497
[TBL] [Abstract][Full Text] [Related]
3. [Chediak-Higashi disease: a new case treated by bone marrow allograft].
Demory JL; Senlecq-Tack S; Decoster A; Duhamel M; Spyckerelle C; Vittu G; Cousin J; Fischer A; Griscelli C
Ann Pediatr (Paris); 1989 Jun; 36(6):387-9. PubMed ID: 2667428
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A
Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome.
Liang JS; Lu MY; Tsai MJ; Lin DT; Lin KH
J Formos Med Assoc; 2000 Jun; 99(6):499-502. PubMed ID: 10925557
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Gordon N; Mullen CA; Tran H; Worth L; Gomez Almaguer D; Chan KW
J Pediatr Hematol Oncol; 2003 Oct; 25(10):824-6. PubMed ID: 14528111
[TBL] [Abstract][Full Text] [Related]
7. Chédiak-Higashi syndrome: hematopoietic chimerism corrects genetic defect.
Trigg ME; Schugar R
Bone Marrow Transplant; 2001 Jun; 27(11):1211-3. PubMed ID: 11551033
[TBL] [Abstract][Full Text] [Related]
8. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia.
Locatelli F; Pession A; Comoli P; Bonetti F; Giorgiani G; Zecca M; Taibi RM; Mongini ME; Ambroselli F; de Stefano P; Severi F; Paolucci G
Br J Haematol; 1996 Jan; 92(1):49-54. PubMed ID: 8562410
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
10. Restoration of neutrophil and platelet function in feline Chediak-Higashi syndrome by bone marrow transplantation.
Colgan SP; Hull-Thrall MA; Gasper PW; Gould DH; Rose BJ; Fulton R; Blanquaert AM; Bruyninckx WJ
Bone Marrow Transplant; 1991 May; 7(5):365-74. PubMed ID: 2070146
[TBL] [Abstract][Full Text] [Related]
11. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.
Tardieu M; Lacroix C; Neven B; Bordigoni P; de Saint Basile G; Blanche S; Fischer A
Blood; 2005 Jul; 106(1):40-2. PubMed ID: 15790783
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell transplantation for Chediak-Higashi syndrome.
Eapen M; DeLaat CA; Baker KS; Cairo MS; Cowan MJ; Kurtzberg J; Steward CG; Veys PA; Filipovich AH
Bone Marrow Transplant; 2007 Apr; 39(7):411-5. PubMed ID: 17293882
[TBL] [Abstract][Full Text] [Related]
13. [The accelerated phase of Chediak-Higashi syndrome].
Bejaoui M; Veber F; Girault D; Gaud C; Blanche S; Griscelli C; Fischer A
Arch Fr Pediatr; 1989 Dec; 46(10):733-6. PubMed ID: 2697195
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation in an osteopetrosis patient: first report in Thailand.
Hongeng S; Pakakasama S; Chuansumrit A; Rerkamnuaychoke B; Nitiyanunt P; Suthutvoravut U; Ungkanont A; Hathirat P
Asian Pac J Allergy Immunol; 1998 Dec; 16(4):193-8. PubMed ID: 10219901
[TBL] [Abstract][Full Text] [Related]
15. Chediak-Higashi syndrome: reversal of increased susceptibility to infection by bone marrow transplantation.
Kazmierowski JA; Elin RJ; Reynolds HY; Durbin WA; Wolff SM
Blood; 1976 Apr; 47(4):555-9. PubMed ID: 769863
[TBL] [Abstract][Full Text] [Related]
16. Chediak-Higashi syndrome: Lessons from a single-centre case series.
Carneiro IM; Rodrigues A; Pinho L; de Jesus Nunes-Santos C; de Barros Dorna M; Moschione Castro APB; Pastorino AC
Allergol Immunopathol (Madr); 2019; 47(6):598-603. PubMed ID: 31477396
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
19. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
